Ventrus Biosciences (VTUS) Files $47.2M Common Shelf
Tweet
Share
E-mailGet Alerts VTUS Hot Sheet
Join SI Premium – FREE
Ventrus Biosciences, Inc. (Nasdaq: VTUS), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to a proposed $47.15 million shares of Common Stock.
The offering is being made through Leerink Swann, Lazard Capital Markets, National Securities Corp., and Rodman & Renshaw, LLC.
The offering is being made through Leerink Swann, Lazard Capital Markets, National Securities Corp., and Rodman & Renshaw, LLC.
Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Lazard, Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
